Michael Wayne Kalb Amarin Corp Plcuk (AMRN) insider trading activity

Michael Wayne Kalb is SVP and CFO of AMARIN CORP PLCUK. Currently has a direct ownership of 337,314 shares of AMRN, which is worth approximately $155,164. The most recent transaction as insider was on Aug 01, 2022, when has been sold 29,682 shares (Ordinary Shares) at a price of $1.33 per share, resulting in proceeds of $39,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 337K

0% 3M change

0% 12M change

Total Value Held $155,164

Michael Wayne Kalb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2022	SELL Payment of exercise price or tax liability	$39,477 $1.33 p/Share	29,682 Reduced 8.09%	337,314 Ordinary Shares
Jul 29 2022	SELL Payment of exercise price or tax liability	$22,903 $1.33 p/Share	17,220 Reduced 5.7%	284,662 Ordinary Shares
Jul 29 2022	BUY Exercise of conversion of derivative security	-	47,767 Added 13.66%	301,882 Ordinary Shares
Feb 28 2022	SELL Payment of exercise price or tax liability	$20,317 $3.27 p/Share	6,213 Reduced 2.42%	250,747 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	16,333 Added 5.98%	256,960 Ordinary Shares
Jan 31 2022	SELL Payment of exercise price or tax liability	$17,865 $3.36 p/Share	5,317 Reduced 2.16%	240,627 Ordinary Shares
Jan 31 2022	BUY Exercise of conversion of derivative security	-	12,733 Added 4.92%	245,944 Ordinary Shares
Dec 31 2021	SELL Payment of exercise price or tax liability	$85,020 $3.35 p/Share	25,379 Reduced 9.81%	233,211 Ordinary Shares
Dec 31 2021	BUY Exercise of conversion of derivative security	-	47,767 Added 15.59%	258,590 Ordinary Shares
Aug 31 2021	SELL Payment of exercise price or tax liability	$16,681 $5.54 p/Share	3,011 Reduced 1.43%	208,107 Ordinary Shares
Aug 31 2021	BUY Exercise of conversion of derivative security	-	6,108 Added 2.81%	211,118 Ordinary Shares
Aug 12 2021	SELL Open market or private sale	$630,000 $5.25 p/Share	120,000 Reduced 36.92%	205,010 Ordinary Shares
Aug 12 2021	BUY Exercise of conversion of derivative security	$308,400 $2.57 p/Share	120,000 Added 26.97%	325,010 Ordinary Shares
Jul 30 2021	SELL Payment of exercise price or tax liability	$12,466 $4.14 p/Share	3,011 Reduced 1.45%	205,010 Ordinary Shares
Jul 30 2021	BUY Exercise of conversion of derivative security	-	6,108 Added 2.85%	208,021 Ordinary Shares
Jun 30 2021	SELL Payment of exercise price or tax liability	$13,489 $4.48 p/Share	3,011 Reduced 1.47%	201,913 Ordinary Shares
Jun 30 2021	BUY Exercise of conversion of derivative security	-	6,108 Added 2.89%	204,924 Ordinary Shares
May 28 2021	SELL Payment of exercise price or tax liability	$13,597 $4.54 p/Share	2,995 Reduced 1.48%	198,816 Ordinary Shares
May 28 2021	BUY Exercise of conversion of derivative security	-	6,112 Added 2.94%	201,811 Ordinary Shares
Apr 30 2021	SELL Payment of exercise price or tax liability	$15,694 $5.24 p/Share	2,995 Reduced 1.53%	193,154 Ordinary Shares
Apr 30 2021	BUY Exercise of conversion of derivative security	-	6,112 Added 3.02%	196,149 Ordinary Shares
Mar 31 2021	SELL Payment of exercise price or tax liability	$19,078 $6.37 p/Share	2,995 Reduced 1.55%	190,037 Ordinary Shares
Mar 31 2021	BUY Exercise of conversion of derivative security	-	6,112 Added 3.07%	193,032 Ordinary Shares
Feb 26 2021	SELL Payment of exercise price or tax liability	$74,511 $6.74 p/Share	11,055 Reduced 5.58%	186,920 Ordinary Shares
Feb 26 2021	BUY Exercise of conversion of derivative security	-	22,446 Added 10.32%	194,980 Ordinary Shares

Also insider at

CINC

CinCor Pharma, Inc. Healthcare

EVP & Chief Financial Officer

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

CFO

CPRX

CATALYST PHARMACEUTICALS, INC. Healthcare

Executive Vice President & CFO

MWK